Its not clear why a substantial minority of individuals dont lose weight when taking a GLP-1 this is a question of tremendous scientific and clinical importance. His own recent study in JAMA Internal Medicine suggests that the drugs work similarly across patient groups based on factors such as age, race and whether people have diabetes, but he said its entirely plausible that there are genetic determinants of GLP-1 effectiveness that have yet to be identified. Precision medicine for obesity For years, personalized medicine has been one of the biggest buzzwords in health care, heralding a new era in which treatments are not one-size-fits-all, but matched to a persons biology
T., et al., Semaglutide Reduces Alcohol Intake and RelapseLike Drinking in Male and Female Rats, eBioMedicine 93 (2023): 104642, 10.1016/j.ebiom.2023.104642
He knows his way around a gym
Ozempic has also undergone rigorous clinical trials to demonstrate its effectiveness for weight loss and diabetes management
GIP receptor activation: Augments insulin secretion, promotes adipocyte lipid uptake under fed conditions, and may contribute to central appetite modulation through pathways distinct from GLP-1R